Umoja Biopharma names new chief business and strategy officer
9 June 2021 -

Umoja Biopharma, an oncology company, announced on Tuesday that it has named David Fontana PhD as its new chief business and strategy officer.

Dr Fontana has served as an executive in the Cell Therapy Franchise and part of the Lymphoma Disease Strategy Team at Bristol Myers Squibb. He has served as vice president of Immuno-Oncology at Pfizer.

Dr Fontana has a PhD in Pharmacology from Wayne State University and PMP certification from the Project Management Institute.